Skip to main content
The Morning Star Shop
Dynamic protein interactions – the new ‘secret of life’?
New research into how proteins bind in cells offers exciting possibilities, write ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL

SCIENTISTS are suckers for stories of discovery. In 1953, James Watson and Francis Crick went for a drink in The Eagle pub in Cambridge after having worked out their model of the DNA double helix.

According to Watson, Crick announced to the other bemused drinkers: “We have found the secret of life.”

A great story — except that, according to Crick, he never said it. But the story became so memorable that it stuck.

Fifty years later, Watson unveiled a blue plaque commemorating the event at the pub, with “the secret of life” at the top.

By then he was well-known within the scientific community for his “flamboyantly chauvinist” views.

His misogynistic portrayal of Rosalind Franklin in his 1968 book the Double Helix had become a legendary example of scientific sexism.

And by the time he unveiled the plaque he was also known for his claims that racist stereotypes had some genetic basis. It must have been comforting to dwell instead on his past glory.

In 2016, Watson admitted he had made the phrase up “for dramatic effect.” But the myth caught the public imagination.

Solving the structure of DNA could be called “the secret of life” because the double helix showed how the sequence of a chemical could store information.

DNA is a double helix. Imagine this as two vertical parallel strands winding around each other, with connections across between them: a twisted spiralling ladder.

The rungs of the ladder are made up of four chemical constituents: adenine (A), cytosine (C), guanine (G) and thymine (T). (The letters are just for simplicity.)

These “bases” of DNA are such that each type will only bind to one of the others: A with T and C with G. Every “rung” is made up of one of these “complementary” base pairings.

Going along one strand of the ladder, the sequence of the bases on that side — for example, AGGC — will always be “mirrored” on the other strand.

Imagine going backwards through AGGC that sequence starting from the end: C binds with G, G with C, another G with C and A with T. So, the other strand will read GCCT.

The sequence could somehow store information that could be translated into proteins, which can interact in the cell to produce life’s complexity.

The double helix means DNA is both a secure store for genetic information and also has an obvious means of copying the information.

If you were to unzip the helix, breaking each rung in two, you’d have two independent strands.

Any one contains exactly the same information. If you add in a soup of many base molecules and the right conditions, you can make each strand into an identical double helix as the bases snap into place along the broken ladders.

But DNA was only part of the puzzle. Once proteins were made, how did they interact with each other in the cell? This was a problem studied by the French scientist, communist and one-time member of the French Resistance, Jacques Monod.

In 1961, Monod (supposedly) walked into the laboratory of his colleague, Agnes Ullmann.

He looked tired and worried and after a few minutes of silence said: “I think I have discovered the second secret of life.” After a few glasses of whisky he explained.

Proteins are made as a long chain of amino acids, but then fold up into complicated three-dimensional shapes.

Compared to DNA, they are much more flexible and active. If DNA has evolved to be as inert as possible, in comparison proteins have a can-do attitude.

A protein usually functions by binding to something else. Many molecular pathways in the cell involve an exquisite sequence of proteins binding to each other.

This had been thought of as a lock and key mechanism: like a lock, each protein could perform one job, but do it perfectly.

Monod’s realisation was that protein structure offered a way for the same protein to change what it did. Say a protein called X binds some other molecule Y at an “active site” somewhere on its structure.

It would be possible that somewhere else on the structure of X, X could bind with another molecule Z.

This binding could be such that this could change the shape of X’s active site with Y — perhaps such that Y could no longer bind.

This might seem abstract, but it is in fact very practical: changing the amounts of Z in the cell will change whether X binds Y or not.

This ability to change structure means that proteins are not static locks which can only ever fit one key: the lock is dynamic.

Their function can be “switched” by other molecules. This transmission of binding at one site to another on the same protein is called “allostery.”

Fundamental to life is the possibility of changing what you do in response to conditions. Allostery is an important way to do this.

Allostery is over 50 years old as a concept. But researchers still usually only study the protein’s active site directly. Proteins are made of amino acids, of which there are 20 possibilities. Mutations cause changes in proteins.

A different one at a single place could produce allosteric effects. Many disease-causing mutations in humans are known to be allosteric, but investigating them is challenging.

Predicting known protein structures is one thing — now thought to be largely “solved” by machine learning — but predicting the effect of a new mutation on the overall structure remains extremely hard. More experimental data is needed.

The issue is that a mutation on a protein can alter the rate at which it binds something else in two ways. One way is more boring: it could change the stability of the protein, meaning that it doesn’t fold up into its usual structure.

More interestingly, it could allow the protein to fold properly, but change the active site through allosteric effects. To disentangle allosteric interactions, one needs to measure both possibilities.

Last month, researchers based in Spain published an article in Nature outlining a method that does this. With a set of relatively simple experimental tests, their method quantifies both the abundance of the folded protein and its binding to another protein.

By generating all possible mutated versions of the protein and running the same measurements on each, they can generate an allosteric “atlas” for a protein: a measure of what changing different sites does.

They studied two well-studied protein-protein interactions from humans. What they found was that around half of all places on the surface of the folded protein structures — far away from the active site — had at least one mutated possibility that was allosteric.

This result suggests that allosteric interactions are frequent in proteins. Future research generating all the possibilities for a protein might be possible, giving us more insight into not only how proteins can evolve but how we might design better drugs to manipulate them.

The researchers’ paper doesn’t have a neat discovery story. As is often the case in science, there is no eureka moment — instead, hundreds of thousands of experiments and patience produce a fascinating new understanding of an old concept.  

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
More from this author
LETHAL PLANS: Keir Starmer visits a defence contractor in Bedfordshire
Science and Society / 4 June 2025
4 June 2025

The distinction between domestic and military drones is more theoretical than practical, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

UNEASY COHABITATION: Southern Ridges, Singapore, 2015 Pic: Zairon/CC
Science and Society / 21 May 2025
21 May 2025

Nature's self-reconstruction is both intriguing and beneficial and as such merits human protection, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

 

POISON: Centivax workers study antivenom to counteract the bites of various snakes at the company lab in San Francisco
Science and Society / 7 May 2025
7 May 2025

A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

SCIENCE AND SOCIETY / 22 April 2025
22 April 2025

Science has always been mixed up with money and power, but as a decorative facade for megayachts, it risks leaving reality behind altogether, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

Similar stories
(Left) Human embryonic stem cells; (right) A patient after i
Features / 26 March 2025
26 March 2025
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries
A 2600BC depiction of a king in Sumer, an early human civili
Science and Society / 22 October 2024
22 October 2024
ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT examine how new genetic research reveals the rapid pace of human evolution in response to agricultural development, offering insights Marx would have found fascinating
MORE QUESTIONS THAN ANSWERS: Field of polymetallic nodules o
Science and Society / 31 July 2024
31 July 2024
ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT explore how metal nodules producing oxygen on the ocean floor complicate the search for extraterrestrial life and our understanding of Earth's early atmosphere
Science and Society / 17 July 2024
17 July 2024
New research reveals how a billion-year-old antiviral defence links humans to deep-sea microbes, showcasing the remarkable conservation of life’s core machinery, explain ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT